| Related LncRNAs | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ID | lncRNA Name | Disease | Method | Sample | Expression pattern | Dysfunction type | Description | PMID | Source |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | expression | Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm. | 19343170 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | mutation | Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL. | 20386740 | LncRNADisease Lnc2Cancer |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | mutation | Variants (rs3217992, A>G;rs1063192, C>T) on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population. | 22034006 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | mutation | Moreover, genome-wide association studies have demonstrated that the 9p21 genomic locus is a hotspot for the risk of stroke, glioma, plexiform neurofibroma and other disorders | 22814587 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | expression | Genetic variants that affect the expression of the ANRIL transcript have been correlated with stroke risk and recurrence in a large prospective study | 22817756 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | mutation | Genetic variation in lncRNA genes causes disease and influences susceptibility | 23791884 | LncRNADisease |
| EL0289 | CDKN2B-AS1 | Stroke | N/A | N/A | N/A | expression | Levels of CDKN2B-AS1/ANRIL in human carotid atherosclerotic plaques and peripheral blood T lymphocytes are linked to rates of ischemic and hemorrhagic stroke. | 24145019 | LncRNADisease |